Sort
15,273 grants matching “antimicrobial resistance”
National Biomedical Information Services
$366,260,951Michael Huerta · National Library Of Medicine · ZIH · FY2024 · LM
National Biomedical Information Services
$358,847,685Michael Huerta · National Library Of Medicine · ZIH · FY2023 · LM
National Biomedical Information Services
$357,194,999Dina Paltoo · National Library Of Medicine · ZIH · FY2025 · LM
National Biomedical Information Services
$347,681,166Jerry Sheehan · National Library Of Medicine · ZIH · FY2022 · LM
National Biomedical Information Services
$340,214,502Jerry Sheehan · National Library Of Medicine · ZIH · FY2020 · LM
National Biomedical Information Services
$332,242,445Patricia Brennan · National Library Of Medicine · ZIH · FY2021 · LM
National Biomedical Information Services
$329,574,691Jerry Sheehan · National Library Of Medicine · ZIH · FY2019 · LM
National Biomedical Information Services
$322,798,326Jerry Sheehan · National Library Of Medicine · ZIH · FY2018 · LM
National Biomedical Information Services
$309,811,058Betsy Humphreys · National Library Of Medicine · ZIH · FY2017 · LM
National Biomedical Information Services
$300,605,102Betsy Humphreys · National Library Of Medicine · ZIH · FY2016 · LM
National Biomedical Information Services
$287,906,483Betsy Humphreys · National Library Of Medicine · ZIH · FY2015 · LM
Antibacterial Resistance Leadership Group (ARLG)
$19,183,975Vance G Fowler · Duke University · UM1 · FY2019 · AI
Antibacterial Resistance Leadership Group (ARLG)
$13,000,000Vance G Fowler · Duke University · UM1 · FY2014 · AI
New players in immune function: identification through RNAi and micro-RNA screens
$12,579,073Mitchell Kronenberg · La Jolla Institute For Immunology · RC4 · FY2010 · AI
Advancing genomic, transcriptomic and functional approaches to combat globally important and emerging pathogens
$12,121,843Daniel E Neafsey · Broad Institute, Inc. · U19 · FY2024 · AI
Development of Novel Antimicrobial Resistance Agents
$11,330,516Achaogen, Inc. · N01 · FY2008 · AI
Antibacterial Resistance Leadership Group (ARLG)
$11,286,280Vance G Fowler · Duke University · UM1 · FY2015 · AI
Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections and Emerging Infectious Diseases
$11,270,810Ryan Cirz · Revagenix, Inc. · N01 · FY2024 · AI
Advanced Development of Therapeutic Products for Antibiotic Resistant Bacteria
$11,122,997Urs Ochsner · Crestone, Inc. · N01 · FY2020 · AI
THIS RESEARCH PROJECT IS A CONTINUATION OF THE JOINT COLLABORATION AT ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES (AFRIMS) OF THE 1977 ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES AGREEMENT. RESEARCH ACTIVITIES WILL INCLUDE BASIC RESEARCH, EPIDEMIOLOGY, AND FIELD TESTING OF VACCINES, DIAGNOSTIC TESTS, AND TREATMENTS FOR TROPICAL DISEASES. U.S. WARFIGHTER THREATS WITH A MAJOR FOCUS ON VECTOR CONTROL, MALARIA, HUMAN IMMUNODEFICIENCY VIRUS (HIV), VECTOR-BORNE VIRUSES, DIARRHEAL ILLNESS ANTIMICROBIAL RESISTANCE, WOUND INFECTIONS AND RESPIRATORY VIRUSES. CORRECTING FUNDING CODE FROM HT0989 TO HT0960 PER CONTRACT.
$10,226,017Afrims Thai Component · · FY2025 · Defense Health Agency
**AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** THE US HAS THE LARGEST BROILER INDUSTRY PRODUCING 9 BILLION BIRDS ANNUALLY. ANTIBIOTICS HAVE BEEN AN INTEGRAL PART OF POULTRY PRODUCTION CONTRIBUTING IN PART TO THE SUSTAINED GROWTH OF BROILER PRODUCTION, WHERE ANTIBIOTIC GROWTH PROMOTERS (AGP'S) ARE USED TO ENHANCE POULTRY PERFORMANCE, FEED EFFICIENCY AND GENERAL HEALTH. RESEARCH INDICATES THAT ANTIBIOTIC-RESTRICTED PRODUCTION CAN ADVERSELY AFFECT BIRD HEALTH, PRODUCTION EFFICIENCY, AND THE ENVIRONMENT. THEREFORE, IN LIGHT OF THE FDA'S DIRECTIVE TO PHASE OUT AGPS IN POULTRY PRODUCTION, IT IS CRITICAL TO ENSURE SUSTAINABILITY OF BROILER PRODUCTION FOR MEETING FUTURE DEMAND.THIS PROPOSAL'S GOAL IS TO PROMOTE SUSTAINABILITY OF BROILER PRODUCTION BY TARGETING THREE MAJOR SYSTEM COMPONENTS IN THE POULTRY SECTOR, NAMELY CHICKEN, HUMANS AND THE ENVIRONMENT. TO ACHIEVE THIS, WE HAVE ASSEMBLED AN INTERDISCIPLINARY TEAM OF RESEARCHERS, EDUCATORS AND EXTENSION PROFESSIONALS WITH THE FOLLOWING OBJECTIVES: 1) CONTROL NECROTIC ENTERITIS AND COCCIDIOSIS IN BROILERS; 2) DEVELOP NOVEL FEED INGREDIENTS FOR IMPROVED PERFORMANCE; 3) PROMOTE BIRD WELFARE; 4) INCREASE BROILER MEAT SAFETY; 5) CONTROL ANTIMICROBIAL RESISTANCE DISSEMINATION IN BROILER PRODUCTION; 6) DEVELOP STRATEGIES FOR RECYCLING OF POULTRY LITTER; 7) ENHANCE CONSUMER CONFIDENCE AND ACCEPTABILITY OF BROILER MEAT; 8) DEVELOP AN OUTREACH PROGRAM TARGETING POULTRY PRODUCERS AND OTHER STAKEHOLDERS; 9) EMPOWER THE FUTURE WORKFORCE WITH SKILLS NEEDED FOR SUSTAINABLE BROILER PRODUCTION; AND 10) ASSESS THE SOCIO-ECONOMIC-ENVIRONMENTAL IMPACT OF PROPOSED INTERVENTIONS.THIS PROJECT WILL ENHANCE BROILER PRODUCTION SUSTAINABILITY BY IMPROVING BIRD HEALTH, HUMAN HEALTH AND ENVIRONMENTAL HEALTH, AND INCREASING CONSUMER ACCEPTABILITY AND ECONOMIC RETURNS TO FARMERS.
$10,000,000University Of Connecticut · · FY2020 · National Institute of Food and Agriculture
Antibacterial Resistance Leadership Group (ARLG)
$10,000,000Vance G Fowler · Duke University · UM1 · FY2016 · AI
Antibacterial Resistance Leadership Group (ARLG)
$10,000,000Vance G Fowler · Duke University · UM1 · FY2018 · AI
DEVELOPMENT OF THERAPEUTICS FOR BIODEFENSE
$9,218,951Yat Sun Or · Enanta Pharmaceuticals, Inc. · N01 · FY2013 · AI
Vaccine and Treatment Evaluation Units: Phase IV Clinical Trial in Adults with Community Acquired Pneumonia to Assess the Effect of Early Empiric Antifungal Treatment of Coccidioidomycosis Pneumonia
$9,208,909Susanna Naggie · Duke University · N01 · FY2019 · AI